{
    "Trade/Device Name(s)": [
        "Human IgA Liquid Reagent Kit for use on the SPAPLUS"
    ],
    "Submitter Information": "The Binding Site",
    "510(k) Number": "K103824",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040435"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFN"
    ],
    "Summary Letter Date": "December 10, 2011",
    "Summary Letter Received Date": "January 23, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR \u00a7866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, E immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "IgA"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin plasma",
        "EDTA plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Binding Site SPAPLUS turbidimetric analyser"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Turbidimetric measurement"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Human IgA Liquid Reagent Kit for quantitative in vitro measurement of human IgA using turbidimetric analysis on SPAPLUS platform",
    "Indications for Use Summary": "For quantitative in vitro determination of human IgA in serum, lithium heparin or EDTA plasma using the SPAPLUS analyser; aids diagnosis of abnormal protein metabolism and immune deficiency when used with other findings",
    "fda_folder": "Immunology"
}